PATENT CLAIM ANALYSIS

Application Number: 15935294
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "234200"]

Abstract:
A combination of a CDK4/6 inhibitor and an mTOR inhibitor for the treatment of cancer.

Claim (Index 12):
The method of  claim 6  wherein the first agent and the second agent are administered in a combined dosage form.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15003860', '14124753', '14214048', '13786955', '14158358']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7915843682613694
- 35 USC 102 Novelty (BERT): 0.5369656115050296
- Combined Prediction Score: 0.7661224925857354
- Mean Citation Score: 326.48982599999994
- Max Citation Score: 374.88705
- Similarity Product: 236.30397176529763

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test